Invivo’s DynaTRIM system is the first commercially available, fully magnetic resonance imaging (MRI)-compatible interventional device for transrectal interventional MRI of the prostate gland.
Pairing DynaCAD for Prostate with DynaTRIM enables a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy.
For more information: www.invivocorp.com
April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...
April 24, 2024 
April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...
April 23, 2024 
April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...
April 17, 2024 
In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...
April 10, 2024 
April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...
April 04, 2024 
March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...
March 29, 2024 
March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...
March 27, 2024 
March 21, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...
March 21, 2024 
In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...
March 19, 2024 
March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...
March 01, 2024